scholarly journals PDB73 - INDIRECT COST-EFFECTIVENESS ANALYSIS OF EMPAGLIFLOZIN COMPARED TO CANAGLIFLOZIN FOR PATIENTS WITH T2DM AND CARDIOVASCULAR DISEASE IN THE SPANISH NATIONAL HEALTH SERVICE

2018 ◽  
Vol 21 ◽  
pp. S130 ◽  
Author(s):  
M. Carrasco Perez ◽  
N. Male ◽  
M. Serra Burriel ◽  
E. Pfarr ◽  
A. Kansal
Keyword(s):  
Cardiovascular Disease ◽  
Cost Effectiveness ◽  
National Health Service ◽  
Health Service ◽  
Indirect Cost ◽  
National Health ◽  
Cost Effectiveness Analysis ◽  
Effectiveness Analysis

Evaluation of the National Health Service (NHS) Direct Pilot Telehealth Program: Cost-Effectiveness Analysis

2018 ◽  
Vol 24 (1) ◽  
pp. 67-76 ◽  
Author(s):  
Malcolm Clarke ◽  
Joanna Fursse ◽  
Nancy E. Brown-Connolly ◽  
Urvashi Sharma ◽  
Russell Jones
Keyword(s):  
Cost Effectiveness ◽  
National Health Service ◽  
Health Service ◽  
National Health ◽  
Cost Effectiveness Analysis ◽  
Program Cost ◽  
Effectiveness Analysis ◽  
Nhs Direct

Cost effectiveness analysis of a next generation risk assessment score for cardiovascular disease

2013 ◽  
Vol 17 (2) ◽  
pp. 132-141
Author(s):  
Evangelos Hytopoulos ◽  
Martin L. Lee ◽  
Michael Beggs ◽  
Cynthia French ◽  
Kuo Bianchini Tong
Keyword(s):  
Cardiovascular Disease ◽  
Risk Assessment ◽  
Cost Effectiveness ◽  
Cost Effectiveness Analysis ◽  
Next Generation ◽  
Assessment Score ◽  
Effectiveness Analysis
Sign in / Sign up

Export Citation Format

Share Document